Advertisement
Device Sectors
Subscribe to Device Sectors
View Sample

FREE Email Newsletter

FluoroPharma Announces $1.6M Capital Raise

June 23, 2011 11:41 am | by Bio-Medicine.Org | News | Comments

BOSTON, June 23, 2011 /- FluoroPharma Medical (OTC.BB: FPMI) announced it has received subscriptions from select accredited investors for gross proceeds of $1.6 million in a private placement offering. The proceeds from this financing together with the previously announced financing in...

PD-Rx Pharmaceuticals Acquires Wilson Medical's EMR

June 23, 2011 11:40 am | by Bio-Medicine.Org | News | Comments

OKLAHOMA CITY, June 23, 2011 /- PD-Rx Pharmaceuticals, Inc., a publicly held corporation, (Symbol: PDRX.PK) today announced the purchase of the Washington EMR, an electronic medical record, from Wilson Medical Software, LLC. Washington EMR is the premier quality, low-cost tool for...

Smith & Nephew Inc. Acquires Privately-Held TENET Medical Engineering, Inc.; Premier Provider of Surgical Patient Positioning Equipment

June 23, 2011 9:45 am | by Bio-Medicine.Org | News | Comments

ANDOVER, Mass., June 23, 2011 /- Smith & Nephew, (NYSE: SNN ; LSE: SN), on behalf of its Endoscopy Division announced today the acquisition of privately-held, Calgary, Alberta-based TENET Medical Engineering, Inc. TENET markets leading edge technology in the area of patient...

Advertisement

Akorn, Inc. Announces Second Quarter 2011 Earnings Release and Conference Call Information

June 23, 2011 9:45 am | by Bio-Medicine.Org | News | Comments

LAKE FOREST, Ill., June 23, 2011 /- Akorn, Inc. (NASDAQ: AKRX ) will host a conference call on Tuesday, August 2, 2011, to discuss second quarter 2011 results followed by a Q&A session.  The company will release earnings the same day before the market opens. Subject:...

BioSurplus Selected to Auction $10 Million in Lab Equipment

June 23, 2011 9:45 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, June 23, 2011 /- BioSurplus today announced the start of a record setting laboratory auction.  Thousands of instruments worth over $10 million will be auctioned via the BioSurplus online auction site at auctions.biosurplus.com. The first auction will have choice laboratory...

AstraZeneca to sell med device biz for $1.8 billion

June 23, 2011 9:42 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Pharmaceuticals giant AstraZeneca plc said it will sell its medical devices unit, the Swedish company Astra Tech, to DENTSPLY International for $1.8 billion.

Aspire Indiana Works with MedInformatix to Customize Practice Management and Electronic Medical Records Solution for Psychiatric Practices

June 23, 2011 8:38 am | by Bio-Medicine.Org | News | Comments

CARMEL, Ind., June 23, 2011 /- Upon joining BehaviorCorp as medical director in 1990, Dr, Jerry Sheward, M.D. recognized the glaring need for then non-existent electronic medical records (EMR) to enable the multi-location behavior health care organization to optimize the services it...

Actavis Hails U.S. Supreme Court Decision in Labeling Cases

June 23, 2011 8:38 am | by Bio-Medicine.Org | News | Comments

MORRISTOWN, N.J., June 23, 2011 /- Actavis applauds the U.S. Supreme Court's decision in the Mensing and Demahy cases as an important step forward for consumer safety and the continued availability of affordable generic medicines. By a 5-4 majority, the court rejected arguments that...

Advertisement

Kinetics Foundation and National Parkinson Foundation (NPF) Announce their Partnership to Evaluate Objective Parkinson's Disease Measurement System

June 23, 2011 8:37 am | by Bio-Medicine.Org | News | Comments

MIAMI, June 23, 2011 /PRNewswire-USNewswire/ -- The National Parkinson Foundation (NPF) and the Kinetics Foundation are pleased to announce their partnership to evaluate Kinetic's Objective Parkinson's Disease Measurement (OPDM) system as a tool for more accurately measuring the symptoms...

Preliminary Results of a Large Scale Study Show ConvaTec Moldable Technologyâ„¢ Skin Barriers Help to Prevent and Improve Peristomal Skin Issues in Ostomy Patients

June 23, 2011 6:49 am | by Bio-Medicine.Org | News | Comments

SKILLMAN, N.J., June 23, 2011 /- ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, announced new observational study results showing that use of ConvaTec Moldable Technology™ Skin Barriers helped to maintain skin...

BioMarin Agrees to Acquire Biologics Manufacturing Plant in Ireland from Pfizer

June 23, 2011 6:47 am | by Bio-Medicine.Org | News | Comments

NOVATO, Calif., June 23, 2011 /- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ) announced today that it has entered into a definitive agreement to acquire a bulk biologics manufacturing plant from Pfizer, located in Shanbally, Cork, Ireland.  The plant, which was completed and...

Adeona Executes Agreement to Initiate Phase IIb Clinical Trial of Proprietary Zinc-Based Therapy in Lou Gehrig's Disease (ALS)

June 23, 2011 6:47 am | by Bio-Medicine.Org | News | Comments

ANN ARBOR, Mich., June 23, 2011 /- Adeona Pharmaceuticals, Inc. (NYSE Amex: AEN ), a developer of innovative medicines for serious central nervous system diseases, announced today that it has expanded its pipeline of proprietary zinc-based therapies to include a planned Phase IIb clinical...

Sirnaomics Seals a Second Partnership Deal with a Chinese Pharmaceutical Company for Developing siRNA Therapeutics

June 23, 2011 6:42 am | by Bio-Medicine.Org | News | Comments

GAITHERSBURG, Md., June 23, 2011 /- Sirnaomics, Inc. ( www.sirnaomics.com ) announced today that the company has signed a partnership agreement with Guangdong Zhongsheng Pharmaceutical Co. Ltd., a Chinese pharmaceutical company trading on the Shenzhen Stock Exchange (SZSE: 002317). The...

Advertisement

AT & T to Wirelessly Connect Zephyr BioHarness

June 23, 2011 6:42 am | by Bio-Medicine.Org | News | Comments

DALLAS, June 23, 2011 /- AT&T * and Zephyr Technology today announced an agreement for AT&T to provide integrated wireless access to the next generation of the Zephyr BioHarness™ designed to measure critical vital signs, including ECG, heart rate, breathing rate, skin...

Solos Endoscopy, Inc. To Launch New Corporate Website

June 23, 2011 6:42 am | by Bio-Medicine.Org | News | Comments

BOSTON, June 23, 2011 /- Solos Endoscopy, Inc. (OTCPK: SNDY) is pleased to announce the launch of their newly designed and interactive website, www.solosendoscopy.com on Friday July 1, 2011. The online venue serves as a "virtual catalog" for existing and new customers and includes...

Update on the Safety of Silicone Gel-Filled Breast Implants - Executive Summary

June 23, 2011 6:34 am | by U.S. Food & Drug Administration | News | Comments

Breast implants are medical devices that are used to augment breast size or to reconstruct the breast following mastectomy or to correct a congenital abnormality. Breast implants consist of a silicone outer shell and a filler (most commonly silicone gel..

Anaplastic Large Cell Lymphoma (ALCL) - Videos Added

June 23, 2011 6:34 am | by U.S. Food & Drug Administration | News | Comments

The FDA has identified a possible association between breast implants and the development of anaplastic large cell lymphoma (ALCL), a rare type of non-Hodgkin?s lymphoma. ALCL is not cancer of the breast tissue. The FDA believes that women with breast...

Reportlinker Adds The Outlook for Medical Devices in Brazil, Russia, India & China

June 23, 2011 4:43 am | by Bio-Medicine.Org | News | Comments

NEW YORK, June 23, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: The Outlook for Medical Devices in Brazil, Russia, India & China...

Centrix Pharmaceutical, Inc. Announces Agreement With CutisPharma, Inc. to Promote FIRST® - Progesterone VGS Compounding Kit

June 23, 2011 4:41 am | by Bio-Medicine.Org | News | Comments

BIRMINGHAM, Ala. June 23, 2011 /- Centrix Pharmaceutical, Inc., a privately-held specialty pharmaceutical company focused on Pediatrics and Women's Health, announces a promotional agreement with CutisPharma, Inc., a Woburn, Massachusetts based company. The partnership will include the...

13D Amendment Filed for RepliGen Corporation

June 23, 2011 4:41 am | by Bio-Medicine.Org | News | Comments

CHICAGO, June 23, 2011 /- Mr. Ronald L. Chez, a private investor, filed an amended 13D for RepliGen Corporation (Nasdaq: RGEN ) with the SEC. RepliGen Corporation is a biopharmaceutical company focused on building an integrated company by developing and marketing innovative drugs that...

Hope for cancer cure lies in the research labs

June 23, 2011 4:37 am | by Mass High Tech: The Journal of New England Technology | News | Comments

MHT Editor James Connolly writes: Whichever variation of cancer someone suffers, the result is - at best - life altering, and, too often, life ending. Yet there is reason for hope in the form of the research being done in labs, many of them right here in Greater Boston.

MRI Featured content

June 23, 2011 4:37 am | by Diagnostic Imaging | News | Comments

MRI Featured content

NewCardio Board of Directors Elects Patrick Maguire Chairman

June 23, 2011 4:36 am | by Bio-Medicine.Org | News | Comments

SANTA CLARA, Calif., June 23, 2011 /- NewCardio, Inc., (OTC BB: NWCI) a cardiac diagnostic technology provider, announced today that Patrick Maguire , MD, PhD, member of the NewCardio board of directors since March of 2008 and a proven leader and a seasoned executive with experience in a...

Radient Pharmaceuticals Corporation Joins OTCQX

June 23, 2011 2:40 am | by Bio-Medicine.Org | News | Comments

NEW YORK, June 23, 2011 /- OTC Markets Group Inc. (OTCQX: OTCM), the company that operates the world's largest electronic marketplace for broker-dealers to trade unlisted stocks, today announced that Radient Pharmaceuticals Corporation (OTCQX: RXPC), the developer and worldwide marketer...

O2h to Provide Chemistry Support to Chromocell

June 23, 2011 12:38 am | by Bio-Medicine.Org | News | Comments

CAMBRIDGE, England, AHMEDABAD, India and NORTH BRUNSWICK, New Jersey, June 23, 2011 /-   Oxygen Healthcare Ltd. (O2h), a Piramal Group Company and Chromocell Corporation , an emerging life sciences company active in both flavors and therapeutics discovery, today signed an agreement...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading